Concepedia

Publication | Closed Access

A randomized, controlled trial of human lymphoblastoid interferon in patients with compensated type C cirrhosis.

34

Citations

0

References

1994

Year

Takafumi Saito, Haruhide Shinzawa, Makoto Kuboki, Masamichi Ishibashi, Hitomi Toda, Yusuke Okuyama, T Nakamura, N. Yamada, Hiroto Wakabayashi, Hideo Togashi
PubMed

Abstract

These findings suggest that IFN administration can be effective and safe in patients with compensated type C cirrhosis, and that it would be worthwhile to evaluate IFN therapy for cirrhotic patients further.